Evidence map›Paper›PMID 30258177›Full record

ArticleNature communications2018

Crystal structure of the red light-activated channelrhodopsin Chrimson.

Kazumasa Oda, Johannes Vierock, Satomi Oishi, Silvia Rodriguez-Rozada, Reiya Taniguchi, Keitaro Yamashita, J Simon Wiegert, Tomohiro Nishizawa, Peter Hegemann, Osamu Nureki

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 166 citations in OpenAlex.

  1. Article
  2. Article
  3. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  4. Multicolor photoreactions of the red light-activated channelrhodopsin Chrimson.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Blue-shifted ancyromonad channelrhodopsins for multiplex optogenetics.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Optogenetic engineering for ion channel modulation.Current opinion in chemical biology · 2025
    Review
  14. Article
  15. Review
  16. Structural Insights Into the Opening Mechanism of C1C2 Channelrhodopsin.Journal of the American Chemical Society · 2025
    Article
  17. Protein design accelerates the development and application of optogenetic tools.Computational and structural biotechnology journal · 2025
    Review
  18. Article
  19. Sensing a rainbow of colors: algal photoreceptors.Frontiers in plant science · 2025
    Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Kazumasa OdaDepartment of Biological Sciences Graduate School of Science, The University of Tokyo, Tokyo, 113-0034, Japan.
Johannes VierockInstitute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, 10115, Berlin, Germany.
Satomi OishiDepartment of Biological Sciences Graduate School of Science, The University of Tokyo, Tokyo, 113-0034, Japan.
Silvia Rodriguez-RozadaResearch Group Synaptic Wiring and Information Processing, Center for Molecular Neurobiology Hamburg (ZMNH), 20251, Hamburg, Germany.
Reiya TaniguchiDepartment of Biological Sciences Graduate School of Science, The University of Tokyo, Tokyo, 113-0034, Japan.
Keitaro YamashitaRIKEN SPring-8 Center, Sayo, 679-5198, Japan.ORCID http://orcid.org/0000-0002-5442-7582
J Simon WiegertResearch Group Synaptic Wiring and Information Processing, Center for Molecular Neurobiology Hamburg (ZMNH), 20251, Hamburg, Germany.ORCID http://orcid.org/0000-0003-0893-9349
Tomohiro NishizawaDepartment of Biological Sciences Graduate School of Science, The University of Tokyo, Tokyo, 113-0034, Japan. t-2438@bs.s.u-tokyo.ac.jp.
Peter HegemannInstitute of Biology, Experimental Biophysics, Humboldt-Universität zu Berlin, 10115, Berlin, Germany. hegemann@rz.hu-berlin.de.
Osamu NurekiDepartment of Biological Sciences Graduate School of Science, The University of Tokyo, Tokyo, 113-0034, Japan. nureki@bs.s.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-1813-7008
The University of Tokyo · JPHumboldt-Universität zu Berlin · DEJapan Science and Technology Agency · JPSPring-8 · JP

Funding

European Research Council 714762Ministry of Education, Culture, Sports, Science, and Technology (MEXT) 16H06294
6 · The paper itself

Abstract

Channelrhodopsins are light-activated ion channels that mediate cation permeation across cell membranes upon light absorption. Red-light-activated channelrhodopsins are of particular interest, because red light penetrates deeper into biological tissues and also enables dual-color experiments in combination with blue-light-activated optogenetic tools. Here we report the crystal structure of the most red-shifted channelrhodopsin from the algae Chlamydomonas noctigama, Chrimson, at 2.6 Å resolution. Chrimson resembles prokaryotic proton pumps in the retinal binding pocket, while sharing similarity with other channelrhodopsins in the ion-conducting pore. Concomitant mutation analysis identified the structural features that are responsible for Chrimson's red light sensitivity; namely, the protonation of the counterion for the retinal Schiff base, and the polar residue distribution and rigidity of the retinal binding pocket. Based on these mechanistic insights, we engineered ChrimsonSA, a mutant with a maximum activation wavelength red-shifted beyond 605 nm and accelerated closing kinetics.

Indexed as

ChannelrhodopsinsChlamydomonasGenetic EngineeringMolecular StructureProtonsSchiff BasesChannelrhodopsinsProtonsSchiff Bases

Identifiers

PMID30258177
PMCPMC6158191
OpenAlexW2890861616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.